Julie S. Shepard

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1)

Joel Schlessinger, Julie S. Shepard, Richard Gower et al. · American Journal of Clinical Dermatology · 2020 · 89 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +14

Clesrovimab for Prevention of RSV Disease in Healthy Infants

Heather J. Zar, Eric A. F. Simões, Shabir A. Madhi et al. · New England Journal of Medicine · 2025 · 47 citations

Pharmacy, Pediatrics, Pharmacotherapy +13

2′-Fucosyllactose Is Well Tolerated in a 100% Whey, Partially Hydrolyzed Infant Formula With <i>Bifidobacterium lactis</i> : A Randomized Controlled Trial

Heidi Storm, Julie S. Shepard, Laura M. Czerkies et al. · Global Pediatric Health · 2019 · 40 citations · Full text

Agriculture, Nutrition, Nutritional Sciences +17

A Phase 1b/2a Trial of a Half-life Extended Respiratory Syncytial Virus Neutralizing Antibody, Clesrovimab, in Healthy Preterm and Full-term Infants

Shabir A. Madhi, Eric A. F. Simões, Armando Acevedo et al. · The Journal of Infectious Diseases · 2024 · 38 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +17

Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine administered concomitantly with measles, mumps, rubella, varicella vaccine in healthy toddlers

Nicola P. Klein, Julie S. Shepard, Lisa Bedell et al. · Vaccine · 2012 · 34 citations

Veterinary Medicine, Immunology, Pediatrics +16